<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1629">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361565</url>
  </required_header>
  <id_info>
    <org_study_id>20odontocovid01</org_study_id>
    <nct_id>NCT04361565</nct_id>
  </id_info>
  <brief_title>Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients</brief_title>
  <official_title>Prevalence and Clinical Evolution of Olfactory and Taste Disorders in Patients Infected by SARS-CoV-2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A novel coronavirus SARS-CoV-2 HAS arose in 2019 in Wuhan, China. Beside the classical
      semiology of this infection, numerous patients described olfactory and teste disorders. These
      symptoms are not described in this coronavirus, neurotropism of coronaviridae has been
      documented before. The aim of the study is to evaluate prevalence of anosmia and dysgeusia
      (olfactory and taste disorders) in coronavirus diagnosed patients and compare with different
      clinical conditions. The second endpoint is to evaluate the duration of these symptoms in
      order to better understand the semiology of this infection.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">April 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anosmia</measure>
    <time_frame>45 days</time_frame>
    <description>Prevalence for anosmia in the COVID-19 + patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ageusia</measure>
    <time_frame>45 days</time_frame>
    <description>Prevalence for ageusia in the COVID-19 + patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of the loss of anosmia ageusia</measure>
    <time_frame>45 days</time_frame>
    <description>Duration measured in days</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>COVID-19 by SARS-CoV-2 Infection</condition>
  <arm_group>
    <arm_group_label>Individuals diagnosed for COVID-19</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals that responded to a online form
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19 diagnosed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Taste Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

